News Study led by Mount Sinai Researcher shows Sotagliflozin is the Only Drug in its class to Significantly Reduce Both Heart Attacks and Strokes
News First-of-its-Kind Study Investigates Differences in Gender-Affirming Vaginoplasty Approaches at the Same Institution